CRANFORD, N.J., Oct. 24, 2019 /PRNewswire/ -- Citius
Pharmaceuticals, Inc. ("Citius") ("Company") (NASDAQ: CTXR), a
specialty pharmaceutical company focused on developing adjunctive
cancer care and critical care drug products, announced today that
the Company will present at the 5th Annual Dawson James
Small Cap Growth Conference on Tuesday, Oct
29, 2019 at 4:30-4:50 PM ET in
Track 2 - Preserve Ballroom B. The conference is being held at the
Wyndham Grand Hotel in Jupiter,
Florida on October 28-29,
2019.
Mr. Leonard Mazur, Chairman of
Citius Pharmaceuticals will be delivering an overview of the
company including recent highlights as well as answering questions
from investors. Citius Pharmaceuticals, Inc. will also be available
for one-on-one meetings. To arrange a meeting with the Company,
please contact Mr. Andrew
Scott: ascott@citiuspharma.com.
About Citius Pharmaceuticals, Inc.
Citius is a specialty pharmaceutical company dedicated to the
development and commercialization of critical care products, with a
focus on anti-infectives, cancer care and unique prescription
products that use innovative, patented or proprietary formulations
of previously-approved active pharmaceutical ingredients. We seek
to achieve leading market positions by providing therapeutic
products that address unmet medical needs; by using previously
approved drugs with substantial safety and efficacy data, we seek
to reduce the risks associated with pharmaceutical product
development and regulatory requirements. Citius develops products
that have intellectual property protection and competitive
advantages to existing therapeutic approaches. For more
information, please visit www.citiuspharma.com.
Contact:
Andrew
Scott
Vice President, Corporate
Development
(O) 908-967-6677 x105
(M) 646-522-8410
ascott@citiuspharma.com
View original
content:http://www.prnewswire.com/news-releases/citius-pharmaceuticals-to-present-at-the-5th-annual-dawson-james-small-cap-growth-conference-300944622.html
SOURCE Citius Pharmaceuticals, Inc.